Clients ranging from startups to multinational public companies to private investment funds turn to Josh for creative, practical and business-minded solutions to their most complex equity compensation issues. Josh advises clients with respect to executive compensation, employee benefits, tax structures, and ERISA aspects of corporate transactions, including mergers and acquisitions, debt and equity financings, and restructurings. 

Download full bio 


  • Baylis Medical Agrees to Sell to Boston Scientific for $1.75 Billion 

  • Flexion Therapeutics Agrees to Sell to Pacira BioSciences 

  • Warby Parker – Direct Listing 

  • ZOLL Medical Agrees to Acquire Itamar Medical for $538 Million 

  • H Code Media Receives Investment From Falfurrias 

  • View all


  • New York University School of Law
    LLM, 2005

  • Boston University School of Law
    JD, 2002

  • University of Pennsylvania
    BA, 1999

Admissions & Credentials



New York